U.S. Markets open in 2 hrs 26 mins
  • S&P Futures

    4,017.75
    -14.75 (-0.37%)
     
  • Dow Futures

    33,655.00
    -130.00 (-0.38%)
     
  • Nasdaq Futures

    11,908.50
    -59.50 (-0.50%)
     
  • Russell 2000 Futures

    1,889.10
    -4.40 (-0.23%)
     
  • Crude Oil

    77.00
    -0.90 (-1.16%)
     
  • Gold

    1,918.80
    -20.40 (-1.05%)
     
  • Silver

    23.19
    -0.54 (-2.27%)
     
  • EUR/USD

    1.0839
    -0.0018 (-0.1626%)
     
  • 10-Yr Bond

    3.5510
    0.0000 (0.00%)
     
  • Vix

    20.53
    +2.02 (+10.91%)
     
  • GBP/USD

    1.2325
    -0.0029 (-0.2354%)
     
  • USD/JPY

    130.4720
    +0.1140 (+0.0875%)
     
  • BTC-USD

    22,894.65
    -199.24 (-0.86%)
     
  • CMC Crypto 200

    519.20
    -18.68 (-3.47%)
     
  • FTSE 100

    7,721.23
    -63.64 (-0.82%)
     
  • Nikkei 225

    27,327.11
    -106.29 (-0.39%)
     

AmerisourceBergen Full Year 2022 Earnings: EPS Misses Expectations

AmerisourceBergen (NYSE:ABC) Full Year 2022 Results

Key Financial Results

  • Revenue: US$238.6b (up 12% from FY 2021).

  • Net income: US$1.70b (up 10% from FY 2021).

  • Profit margin: 0.7% (in line with FY 2021).

  • EPS: US$8.15 (up from US$7.48 in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

AmerisourceBergen EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 15%.

Looking ahead, revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 3.0% from a week ago.

Risk Analysis

You still need to take note of risks, for example - AmerisourceBergen has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here